Experience

Springboard Enterprises

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Advisory Board Member

  • Jan 2022 - Present

  United States



McCoy BioPharma Consulting

• Managing Director

  • Sep 2021 - Present

  San Francisco Bay Area Lead pipeline strategy, new product planning, insights, commercial assessments, competitive intelligence, forecasting and decision support for biopharmaceutical companies, startups and investors. Clients include CARGO, DICE, NGM and Jazz.



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Head of Oncology Insights, Global Product Strategy

  • Jul 2017 - Jun 2021

  South San Francisco, CA Led global team of 40 insights experts who leveraged customer insights, analytics and forecasting to support commercial and clinical decision making for over 20 on-market oncology assets, and many others in the pipeline. As a member of Global Oncology Leadership team, acted as key strategic thought partner to global oncology commercial & clinical leadership and to leadership of partners such as Research, Portfolio Planning, Global Access and major Roche affiliates.

• Associate Director & Chief of Staff, Global Product Strategy Oncology

  • Dec 2015 - Jun 2017

  South San Francisco Led GPS Oncology Leadership Team to be a high performing team through strategic initiatives, goal setting, communication and culture development. Spearheaded development and rollout of global Oncology Strategy across Roche.



Genentech

• United States
• Biotechnology Research
• 700 & Above Employee

• Group Product Manager, Managed Care Marketing

  • Dec 2013 - Dec 2015

  Managed team of marketers aligned to the BioOncology business unit and 30 US Regional General Managers (account managers focused on regional commercial / public payers, hospitals, ACOs).

• Group Manager, Market Planning

  • Apr 2006 - Dec 2013

  Built high-performing team of six Market Planners supporting Tarceva, Xeloda, Zelboraf / Erivedge. Acted as a trusted advisor to franchise head and engaged member of Oral Oncolytics Franchise Leadership Team. Built team of ten Market Planners in the RA franchise (Rituxan / Actemra) and pipeline in AAV, sJIA, Lupus, and MS. Advised leadership on RA franchise strategy, priorities, message development, and tactics. Led team through integration of Roche & Genentech to perform as one franchise.